GlassScriptPhysician profile
Meghan Neil
NPI 1245098912
$1,354.75
in general payments reported to CMS, 2019-2025
16 companies · $666 in 2025
The $666 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $689 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,179.77 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $644.71 | 2024-2025 | Tremfya |
| Abbvie INC. | $113.00 | 2024-2025 | |
| Lilly USA, LLC | $112.74 | 2024-2025 | Taltz, Ebglyss, Olumiant |
| Regeneron Healthcare Solutions, INC. | $104.41 | 2024-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $71.10 | 2024-2025 | |
| Incyte Corporation | $54.36 | 2024-2025 | Opzelura |
| Galderma Laboratories, L.P. | $36.17 | 2024 | |
| Leo Pharma INC. | $31.73 | 2024 | Adbry |
| Amgen INC. | $31.49 | 2024 | Otezla |
| Ucb, INC. | $30.72 | 2024 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $29.95 | 2024-2025 | Zoryve |
| Novartis Pharmaceuticals Corporation | $27.30 | 2025 | |
| Almirall LLC | $18.28 | 2025 | Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $16.45 | 2025 | Siliq, Jublia, Cabtreo |
| E.R. Squibb & Sons, L.L.C. | $16.25 | 2025 | Sotyktu |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Neil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.